Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: A meta-analysis

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 10150-10161

  Li, L ^a   Wang, S J ^a   Shi, K ^a   Chen, D ^a   Jia, H ^a   Zhu, J ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Microsomal transfer protein; Non alcoholic fatty liver disease; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; LIPID TRANSFER PROTEIN; MICROSOMAL TRANSFER PROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; META ANALYSIS; MTP GENE; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; CASE CONTROL STUDY; EARLY DIAGNOSIS; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MALE;

CARRIER PROTEINS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84919397657     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.December.4.9     Document Type: Article

References (40)

1. Alisi A, Cianfarani S, Manco M, Agostoni C, et al. (2012). Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Annals Med. 44: 29-40.
2. Carulli L, Canedi I, Rondinella S, Lombardini S, et al. (2009). Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig. Liver Dis. 41: 823-828.
3. Day CP (2006). Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26: 1021-1028.
4. Day CP (2010). Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig. Dis. 28: 255-260.
5. Di Filippo M, Créhalet H, Samson-Bouma ME, Bonnet V, et al. (2012). Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia. J. Lipid Res. 53: 548-555.
6. Dongiovanni P, Valenti L, Rametta R, Daly A, et al. (2010). Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut 59: 267-273.
7. Dowman JK, Tomlinson JW and Newsome PN (2010). Pathogenesis of non-alcoholic fatty liver disease. QJM 103: 71-83.
8. Duvnjak M, Barsić N, Tomasić V and Lerotić I (2009). Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression. World J. Gastroenterol. 15: 6023-6027.
9. El-Koofy NM, El-Karaksy HM, Mandour IM, Anwar GM, et al. (2011). Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. Saudi J. Gastroenterol. 17: 265-270.
10. Fan JG and Farrell GC (2009). Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 50: 204-210.
11. Fon Tacer K and Rozman D (2011). Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipids 2011: 783976.
12. Gambino R, Cassader M, Pagano G, Durazzo M, et al. (2007). Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 45: 1097-1107.
13. Hashemi M, Hoseini H, Yaghmaei P, Moazeni-Roodi A, et al. (2011). Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell. Biol. 30: 569-575.
14. Hussain MM, Rava P, Walsh M, Rana M, et al. (2012). Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. 9: 14.
15. Liu Q, Bengmark S and Qu S (2010). The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 9: 42.
16. Malaguarnera M, Di Rosa M, Nicoletti F and Malaguarnera L (2009). Molecular mechanisms involved in NAFLD progression. J. Mol. Med. 87: 679-695.
17. Mirandola S, Osterreicher CH, Marcolongo M, Datz C, et al. (2009). Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C. Liver Int. 29: 557-565.
18. Musso G, Gambino R and Cassader M (2010). Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. J. Nutr. Biochem. 21: 834-840.
19. Musso G, Gambino R, De Michieli F, Biroli G, et al. (2007). Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am. J. Clin. Nutr. 86: 661-671.
20. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, et al. (2004). Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 40: 781-786.
21. Oliveira CP, Stefano JT, Cavaleiro AM, Zanella Fortes MA, et al. (2010). Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 25: 357-361.
22. Pagano C, Soardo G, Esposito W, Fallo F, et al. (2005). Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur. J. Endocrinol. 152: 113-118.
23. Patton HM, Yates K, Unalp-Arida A, Behling CA, et al. (2010). Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 105: 2093-2102.
24. Pereira IV, Stefano JT and Oliveira CP (2011). Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol. 5: 245-251.
25. Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
26. Petit JM, Masson D, Minello A, Duvillard L, et al. (2006). Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients. Mol. Genet. Metab. 88: 196-198.
27. Poniachik J, Csendes A, Díaz JC, Rojas J, et al. (2006). Increased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 33: 252-257.
28. Postic C and Girard J (2008). The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab. 34: 643-648.
29. Serre D, Montpetit A, Paré G, Engert JC, et al. (2008). Correction of population stratification in large multi-ethnic association studies. PLoS One 3: e1382.
30. Shimabukuro M, Higa M, Yamakawa K, Masuzaki H, et al. (2013). Miglitol, a-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study. Int. J. Cardiol. 167: 2108-2113.
31. Siqueira ER, Oliveira CP, Correa-Giannella ML, Stefano JT, et al. (2012). MTP-493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients. Braz. J. Med. Biol. Res. 45: 72-77.
32. Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25: 603-605.
33. Sugihara T, Koda M, Kishina M, Kato J, et al. (2013). Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model. Hepatol. Res. 43: 547-556.
34. Sun Y, Lian Z, Jiang C, Wang Y, et al. (2012). Beneficial metabolic effects of 2', 3', 5'-tri-acetyl-N6-(3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters. PLoS One 7: e32115.
35. Tannapfel A, Denk H, Dienes HP, Langner C, et al. (2011). Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 458: 511-523.
36. Wong VW, Wong GL, Yip GW, Lo AO, et al. (2011). Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60: 1721-1727.
37. Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, et al. (2007). Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. Alcohol Clin. Exp. Res. 31: S15-S21.
38. Yoon D, Lee SH, Park HS, Lee JH, et al. (2005). Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease. J. Korean Med. Sci. 20: 421-426.
39. Zampino R, Ingrosso D, Durante-Mangoni E, Capasso R, et al. (2008). Microsomal triglyceride transfer protein (MTP)-493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. J. Viral Hepat. 15: 740-746.
40. Zintzaras E and Ioannidis JP (2005). HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21: 3672-3673.